Pharmaceutical Preparations · DE · CIK 1840439
Develops oral, small molecule drugs for diabetes, obesity, and metabolic diseases
Comparable business profile · signals at a glance
In the 90 days to Dec 11, 2025: 2 insiders bought $196K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 11, 2025 | Erdtmann Rainer MSee Remarks | Buy | 30,000 | $1.43 | $43K |
| Dec 2, 2025 | Hitchcock Michael J.M.Interim CEO | Buy | 100,000 | $0.99 | $99K |
| Dec 1, 2025 | Erdtmann Rainer MSee Remarks | Buy | 10,000 | $1.05 | $11K |
| Nov 28, 2025 | Erdtmann Rainer MSee Remarks | Buy | 40,000 | $1.10 | $44K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.